Cobblestone Asset Management’s Invesco Senior Loan ETF BKLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Sell
50,401
-1,337
-3% -$27.4K 0.41% 36
2026
Q2
$1.05M Buy
51,738
+3,988
+8% +$81.8K 0.44% 39
2026
Q1
$975K Buy
47,750
+6,720
+16% +$139K 0.44% 41
2025
Q4
$862K Buy
41,030
+17,289
+73% +$362K 0.39% 39
2025
Q3
$497K Sell
23,741
-843
-3% -$17.7K 0.23% 53
2025
Q2
$514K Sell
24,584
-2,641
-10% -$54.8K 0.27% 50
2025
Q1
$564K Buy
27,225
+13,880
+104% +$291K 0.33% 42
2024
Q4
$281K Buy
13,345
+987
+8% +$20.8K 0.18% 45
2024
Q3
$260K Sell
12,358
-22
-0.2% -$462 0.16% 42
2024
Q2
$260K Buy
12,380
+477
+4% +$10.1K 0.17% 41
2024
Q1
$252K Buy
11,903
+11
+0.1% +$232 0.17% 40
2023
Q4
$252K Buy
+11,892
New +$249K 0.19% 35

Other funds holding BKLN

Cobblestone Asset Management's BKLN Position: Q3 2026 in Review

Cobblestone Asset Management reduced its Invesco Senior Loan ETF (BKLN) stake by 2.6% in Q3 2026, selling an estimated $27.4K and leaving 50,401 shares worth $1.03M. The position accounts for 0.41% of the portfolio, ranked #36.

Cobblestone Asset Management first reported a position in BKLN in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.05M in Q2 2026. 377 funds tracked by Wall St. Rank hold BKLN as of Q3 2026.

  • Cobblestone Asset Management held 50,401 shares of Invesco Senior Loan ETF worth $1.03M as of Q3 2026.
  • Cobblestone Asset Management sold 1,337 Invesco Senior Loan ETF shares in Q3 2026, an estimated $27.4K.
  • Invesco Senior Loan ETF made up 0.41% of Cobblestone Asset Management's portfolio in Q3 2026, its #36 holding.
  • Cobblestone Asset Management first reported a position in Invesco Senior Loan ETF in Q4 2023 and has held it in 12 quarters since.
  • Cobblestone Asset Management's Invesco Senior Loan ETF position peaked at $1.05M in Q2 2026.
  • 377 funds tracked by Wall St. Rank held Invesco Senior Loan ETF as of Q3 2026.

Based on Cobblestone Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.